- Conditions
- Renal Allograft Recipients
- Locations
-
- Local Institution - 0042 Birmingham, Alabama, United States
- Local Institution - 0041 Los Angeles, California, United States
- Local Institution - 0014 Washington D.C., District of Columbia, United States
- Local Institution - 0022 Hollywood, Florida, United States
Clinical trial condition
Renal Allograft Recipients
Explore clinical trials studying Renal Allograft Recipients. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Renal Allograft Recipients trial results
NCT07333495
- Conditions
- Kidney Transplant, Renal Allograft, Renal Allograft Recipients
- Locations
-
- Sinopharm Dongfeng General Hospital, Dongfeng Motor Corporation and Hubei University of Medicine. Shiyan, Hubei, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Shanxi Medical University Taiyuan, Shanxi, China
Completed
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
NCT00895583
- Conditions
- Graft Rejection, Kidney Transplant, Renal Allograft Recipients, +1 more
- Locations
-
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Aurora, Colorado, United States
- Pfizer Investigational Site Denver, Colorado, United States
Completed
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
NCT00470665
- Conditions
- Renal Allograft Recipients
- Locations
-
Not specified